vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and NATIONAL PRESTO INDUSTRIES INC (NPK). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $164.0M, roughly 1.7× NATIONAL PRESTO INDUSTRIES INC). On growth, NATIONAL PRESTO INDUSTRIES INC posted the faster year-over-year revenue change (21.7% vs -16.5%). NATIONAL PRESTO INDUSTRIES INC produced more free cash flow last quarter ($12.4M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

National Presto Industries is a company founded in 1905 in Eau Claire, Wisconsin. Originally called "Northwestern Steel and Iron Works" the company changed its name to the "National Pressure Cooker Company" in 1929 and then National Presto Industries, Inc. 1953. The company originally produced pressure canners for commercial, and later home, use. Beginning in 1939, the company introduced small home-use cooking appliances. The company was admitted to the New York Stock Exchange on March 3, 1969.

HCM vs NPK — Head-to-Head

Bigger by revenue
HCM
HCM
1.7× larger
HCM
$270.8M
$164.0M
NPK
Growing faster (revenue YoY)
NPK
NPK
+38.3% gap
NPK
21.7%
-16.5%
HCM
More free cash flow
NPK
NPK
$9.1M more FCF
NPK
$12.4M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
NPK
NPK
Revenue
$270.8M
$164.0M
Net Profit
$2.0M
Gross Margin
37.7%
16.9%
Operating Margin
-13.2%
11.4%
Net Margin
0.7%
Revenue YoY
-16.5%
21.7%
Net Profit YoY
-83.6%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
NPK
NPK
Q4 25
$270.8M
$164.0M
Q3 25
$115.5M
Q2 25
$277.7M
$120.4M
Q1 25
$324.5M
$103.6M
Q4 24
$134.7M
Q3 24
$91.8M
Q2 24
$305.7M
$85.1M
Q1 24
$76.7M
Net Profit
HCM
HCM
NPK
NPK
Q4 25
$2.0M
Q3 25
$5.3M
Q2 25
$455.0M
$5.2M
Q1 25
$11.9M
$7.6M
Q4 24
Q3 24
$8.1M
Q2 24
$25.8M
$6.1M
Q1 24
$6.6M
Gross Margin
HCM
HCM
NPK
NPK
Q4 25
37.7%
16.9%
Q3 25
13.9%
Q2 25
0.1%
15.4%
Q1 25
48.0%
17.5%
Q4 24
24.3%
Q3 24
18.8%
Q2 24
41.1%
17.3%
Q1 24
18.1%
Operating Margin
HCM
HCM
NPK
NPK
Q4 25
-13.2%
11.4%
Q3 25
5.6%
Q2 25
-1.3%
5.1%
Q1 25
-5.0%
8.8%
Q4 24
17.3%
Q3 24
10.0%
Q2 24
-9.0%
7.5%
Q1 24
8.2%
Net Margin
HCM
HCM
NPK
NPK
Q4 25
0.7%
Q3 25
4.6%
Q2 25
163.8%
4.3%
Q1 25
3.7%
7.3%
Q4 24
Q3 24
8.8%
Q2 24
8.4%
7.1%
Q1 24
8.6%
EPS (diluted)
HCM
HCM
NPK
NPK
Q4 25
$0.00
Q3 25
Q2 25
$0.52
Q1 25
$0.01
Q4 24
Q3 24
Q2 24
$0.03
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
NPK
NPK
Cash + ST InvestmentsLiquidity on hand
$1.4B
$3.8M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$395.1M
Total Assets
$1.8B
$500.7M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
NPK
NPK
Q4 25
$1.4B
$3.8M
Q3 25
$4.6M
Q2 25
$1.4B
$4.8M
Q1 25
$836.1M
$5.5M
Q4 24
$22.7M
Q3 24
$33.2M
Q2 24
$802.5M
$53.4M
Q1 24
$87.9M
Total Debt
HCM
HCM
NPK
NPK
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
NPK
NPK
Q4 25
$1.2B
$395.1M
Q3 25
$379.8M
Q2 25
$1.2B
$374.1M
Q1 25
$759.9M
$368.6M
Q4 24
$367.6M
Q3 24
$346.6M
Q2 24
$740.1M
$338.1M
Q1 24
$331.6M
Total Assets
HCM
HCM
NPK
NPK
Q4 25
$1.8B
$500.7M
Q3 25
$503.8M
Q2 25
$1.8B
$471.9M
Q1 25
$1.3B
$455.3M
Q4 24
$453.4M
Q3 24
$428.9M
Q2 24
$1.3B
$418.1M
Q1 24
$417.5M
Debt / Equity
HCM
HCM
NPK
NPK
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
NPK
NPK
Operating Cash FlowLast quarter
$8.2M
$13.9M
Free Cash FlowOCF − Capex
$3.4M
$12.4M
FCF MarginFCF / Revenue
1.2%
7.6%
Capex IntensityCapex / Revenue
1.8%
0.9%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-36.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
NPK
NPK
Q4 25
$8.2M
$13.9M
Q3 25
$-24.6M
Q2 25
$-72.9M
$-10.9M
Q1 25
$40.3M
$12.5M
Q4 24
$-7.6M
Q3 24
$-17.5M
Q2 24
$-39.8M
$-33.9M
Q1 24
$5.6M
Free Cash Flow
HCM
HCM
NPK
NPK
Q4 25
$3.4M
$12.4M
Q3 25
$-24.7M
Q2 25
$-82.2M
$-13.4M
Q1 25
$32.5M
$-10.5M
Q4 24
$-11.3M
Q3 24
$-20.3M
Q2 24
$-49.9M
$-34.5M
Q1 24
$5.2M
FCF Margin
HCM
HCM
NPK
NPK
Q4 25
1.2%
7.6%
Q3 25
-21.4%
Q2 25
-29.6%
-11.1%
Q1 25
10.0%
-10.2%
Q4 24
-8.4%
Q3 24
-22.1%
Q2 24
-16.3%
-40.6%
Q1 24
6.7%
Capex Intensity
HCM
HCM
NPK
NPK
Q4 25
1.8%
0.9%
Q3 25
0.1%
Q2 25
3.3%
2.0%
Q1 25
2.4%
22.2%
Q4 24
2.7%
Q3 24
3.1%
Q2 24
3.3%
0.8%
Q1 24
0.5%
Cash Conversion
HCM
HCM
NPK
NPK
Q4 25
4.21×
Q3 25
-4.63×
Q2 25
-0.16×
-2.12×
Q1 25
3.38×
1.64×
Q4 24
Q3 24
-2.16×
Q2 24
-1.54×
-5.58×
Q1 24
0.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons